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Circadian FIuctuations in 
Anxiety Disorders 
To the Editor: 
Predictable rhythmic fluctuations, especially cir- 
cadian, have been observed in a wide variety of phys- 
iologicai and psychological functions. Abno~a~ities 
of circadian patterns have been documented in people 
with depression, including a tendency for maximal 
severity of depression in the morning; however, pa- 
tients with anxiety or mixed depression/anxiety report 
a tendency for symptoms to be worse later in the day 
(Kiloh and C&side 1963; Mendefs and Cochrane 1%8; 
Roth et al. 1972; Mathew et al. 1982; Mullaney 1984; 
Faravelli et al. 1985; Von Zerssen et al. 1985). De- 
spite this observation, no systematic study of poten- 
tial circadian fluctuations of anxiety in people with 
clinical anxiety disorders has appeared; that is the 
purpose of this investigation. 
Thirty patients (20 with DSM-lli-defined panic 
attacks and 10 with other anxiety disorders; 23 women; 
mean age 36 years) at the time of diagnostic evalu- 
ation retrospectively rated their average anxiety level 
at five different times of day (early morning, late 
morning,, mjdaftemoon, early evening, and late eve- 
ning) on a 6point scale (none, very mild, mild, mod- 
erate, severe, and very severe) for a good day, an 
average day, and a bad day for the previous several 
months. Nineteen of these women who had active 
menstrual cycles also rated their anxiety on a 5-point 
scale (worse, somewhat worse, unchanged, some- 
what better, and better) at four times during the men- 
strual cycle (premenstrual week, during menses, 
postmenstrual week, and midcycle). Finally, all pa- 
tients who reported panic attacks rated the frequency 
of attacks that woke them from sleep. 
A statistically significant fluctuation in severity of 
anxiety throughout the day was observed (repeated 
measures Analysis of Variance: F = 3.30, p < 0.05); 
when only patients with panic attacks were included, 
the severity level and pattern through the day were 
very similar. The lowest level was at late morning 
and the highest early evening, with a fluctuation of 
approximately one-half of a rating gradation over the 
five time points (e.g., mild to midway between mild 
and moderate for an average day). There was also a 
statistically significant fluctuation over the menstrual 
cycle, with peak severity (somewhat worse) in the 
premenst~a1 week (repeated measures Analysis of 
Variance: F = 6.70, p < 0.01). Forty-five percent 
of the patients with panic attacks reported that attacks 
sometimes awoke them from sleep; for these patients, 
approximately 11% of the attacks occurred during 
sleep. 
These results demons~ate that, unlike melan- 
cholic depression, people with anxiety disorders, par 
titularly panic attacks, tend to experience increased 
symtoms later in the day. Although the fluctuation 
through the day was not great, these results are in 
agreement with the prior unsystematic studies listed 
above. Menstrually related fluctuations of anxiety se- 
verity were also observed. Prior studies of men- 
strually related fluctuations of anxiety in normal women 
have produced mixed results (Golub 1976; Alplanalp 
et al. 1977; Lahmeyer et al. 1982; Veith et al. 1984; 
Van Den Akker and Steptoe 1985). Although it has 
been claimed that panic attacks are more likely to 
occur premenstrually (Rubinow and Roy-Byrne 1984), 
this is the first published documentation. Further study 
will be necessary to elucidate the mechanisms of the 
observed fluctuations. 
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Lithium and Haloperidol 
7‘0 the Editor: 
Pandey et al. ( 1979) showed that phenothiazines 
enhanced the concentration of lithium (Li) in the red 
blood cell (RBC). However, the effect of Li on the 
concentration of neuroleptics in the RBC has not been 
studied. 
We hypothesized that Li increases the haloperidol 
(HAL) concentration in the RBC. In our pilot study 
of six patients, the addition of Li to HAL resulted in 
an increase of HAL in the RBC (Nemes et al. 1985). 
We then studied 17 patients with diagnoses of 
chronic schizophrenia or schizoaffectivc disorder 
(DSM-III). Their mean age was 42 years. Average 
age at tirst psychiatric hospitalization was 20 years. 
The study lasted IO weeks. In the tirst week of 
the study. HAL dose wab titrated for each patient to 
obtain the clinically optimal dose: this dose then rc- 
mained fixed for the subsequent 9 weeks. The mean 
tixed HAL dose was 44 mg daily (range 20-90 mg! 
day). Patients also received placebo Li during thz 
first 4 weeks of the study; active Li was added m 
week 5. Li plasma levels. ranging from 0.21 to 1 .I!1 
mcqiliter. were maintained for 4 weeks. Following 
this period. placebo Li administration was resumed 
for 2 weeks. Blood levels of HAL and reduced HAL 
(RHAL) (Korpi et al. 1984) were measured weekly 
throughout the study. Samples were drawn on 3 con. 
secutive days before active Li was added (week 4) 
fin order to establish steady state) and on the last 3 
days of the combined HAL-Li period (week 8). 1.1 
levels were determined weekly until the end of the 
study after active Li was introduced 
